Browse by author
Lookup NU author(s): Dr Ilona Obara
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License (CC BY-NC-ND).
©2015 International Association for the Study of Pain. Activated mammalian target of rapamycin (P-mTOR) has been shown to maintain the sensitivity of subsets of small-diameter primary afferent A-nociceptors. Local or systemic inhibition of the mTOR complex 1 (mTORC1) pathway reduced punctate mechanical and cold sensitivity in neuropathic pain and therefore offered a new approach to chronic pain control. In this study, we have investigated the effects of the rapamycin analog temsirolimus (CCI-779) on itch. Bouts of scratching induced by the histamine-dependent pruritogenic compound 48/80 and histamine-independent pruritogens, chloroquine and SLIGRL-NH2, injected intradermally were significantly reduced by local (intradermal) or systemic (intraperitoneal, i.p.) pretreatment with CCI-779. We also investigated the action of metformin, a drug taken to control type 2 diabetes and recently shownto inhibitmTORC1in vivo. Although the response to nonhistaminergic stimuli was reduced at all of the time points tested, scratching to compound 48/80 wasmodified bymetformin only when the drugwas injected 24 hours before this pruritogen. We also examined the colocalization of P-mTOR with gastrin-releasing peptide, a putative marker for some itch-sensitive primary afferents, and found that P-mTORwas coexpressed in less than 5%of gastrin-releasing peptide-positive fibers in themouse skin. Taken together, the data highlight the role that P-mTOR-positive A-fibers play in itch signaling and underline the importance of the mTORC1 pathway in the regulation of homeostatic primary afferent functions such as pain and itch. The actions of the antidiabetic drug metformin in ameliorating nonhistamine-mediated itch also suggest a new therapeutic route for the control of this category of pruritus.
Author(s): Obara I, Medrano MC, Signoret-Genest J, Jimenez-Diaz L, Geranton SM, Hunt SP
Publication type: Article
Publication status: Published
Journal: Pain
Year: 2015
Volume: 156
Issue: 8
Pages: 1519-1529
Print publication date: 01/08/2015
Acceptance date: 10/04/2015
Date deposited: 01/09/2017
ISSN (print): 0304-3959
ISSN (electronic): 1872-6623
Publisher: Lippincott Williams and Wilkins
URL: https://doi.org/10.1097/j.pain.0000000000000197
DOI: 10.1097/j.pain.0000000000000197
PubMed id: 25906350
Altmetrics provided by Altmetric